Concepedia

Yu Tang

YT

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2024

Affiliations

Singapore Institute for Clinical Sciences(Current)

Yu Tang is an author at Singapore Institute for Clinical Sciences specializing in breast cancer pharmacotherapy, oncogenic signaling pathways, and pik3ca mutations.

Publications per year

2024–2025

3

Publications

3

PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer

Hongyan Zhang, Longlong Zhang, Yuna He et al. · Cancer Letters · 2024 · 33 citations

, , +16

Condensate nanovaccine adjuvants augment CD8+ T-Cell-dependent antitumor immunity through mtDNA leakage-triggered cGAS-STING axis activation

Yu Tang, Zhiyuan Luo, Lingling Han et al. · Signal Transduction and Targeted Therapy · 2025 · 13 citations · Full text

, , +17

Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1

Ruizhi Zhang, Gan Mao, Yu Tang et al. · Cancer Immunology Immunotherapy · 2024 · 11 citations · Full text

, , +17

1–3 of 3